In an in vitro and in vivo study by Cui and colleagues to investigate the potential therapeutic effect of eugenolagainst the up-regulated level of Tripartite motif 59 (TRIM59) and p65 in NSCLC, eugenoltherapy significantly decreased xenograft tumour growth and extended the total survival of tumour-bearing mice. Here, TRIM59 is linked to neoplasm.